Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy for prostate cancer.

Timothy Gilligan1, Philip W Kantoff

  • 1Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

Urology
|September 17, 2002
PubMed
Summary

Cytotoxic chemotherapy is an emerging treatment for advanced prostate cancer, offering palliation for hormone-refractory disease. Research is exploring various chemotherapy combinations and earlier disease applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IDH1 Mutations Are Associated with Favorable Outcomes in Prostate Cancer.

European urology·2026
Same author

Patient-Clinician Communication: ASCO Guideline Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

International Society of Urological Pathology (ISUP) Consensus Conference on Precursor Lesions: Working Group 4 Precursor Lesions of Testis Results of a Premeeting Survey.

The American journal of surgical pathology·2026
Same author

Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing Therapy.

Clinical genitourinary cancer·2025
Same author

Tumor Cholesterol Synthesis, Statin Use, and Lethal Prostate Cancer.

Molecular cancer research : MCR·2025
Same author

Minimizing Toxicity From Chemotherapy in Early-Stage Testicular Cancer.

JCO oncology practice·2025

Area of Science:

  • Oncology
  • Urology
  • Pharmacology

Background:

  • Androgen deprivation therapy (ADT) is standard for advanced and selected localized prostate cancer.
  • ADT serves as a model for targeted therapies in prostate cancer.
  • Development of novel targeted therapies alongside chemotherapy is crucial.

Purpose of the Study:

  • To review the emerging role of cytotoxic chemotherapy in prostate cancer treatment.
  • To evaluate the efficacy and toxicity of various chemotherapy regimens.
  • To explore the application of chemotherapy in different stages of prostate cancer.

Main Methods:

  • Review of early studies combining mitoxantrone and corticosteroids.
  • Analysis of estramustine combined with microtubule inhibitors (e.g., taxanes) for hormone-refractory prostate cancer.
  • Exploration of estramustine-omitting regimens (taxane alone or with biologics) and triplet therapies.
  • Investigation into chemotherapy use in earlier disease settings (neoadjuvant, adjuvant, serologically relapsing).

Main Results:

  • Early chemotherapy regimens (mitoxantrone/corticosteroid) showed minimal toxicity and significant palliation in symptomatic hormone-refractory prostate cancer.
  • Estramustine combined with taxanes appears highly active in hormone-refractory prostate cancer, though its value and toxicity are debated.
  • Ongoing research is evaluating estramustine-free regimens and triplet therapies.
  • Data on chemotherapy in earlier disease stages are beginning to emerge.

Conclusions:

  • Cytotoxic chemotherapy is a viable and emerging treatment option for advanced prostate cancer, particularly for hormone-refractory disease.
  • Combination chemotherapy, especially estramustine-taxane doublets, shows activity but requires careful consideration of toxicity.
  • Future research directions include optimizing chemotherapy regimens, exploring novel combinations, and assessing its utility in earlier disease stages.

Related Experiment Videos